en.cmicgroup.comCMIC Group | Contract Research Organization

EN | JP About CMIC About CMIC History of CMIC Personal Health Value Creator CMIC's Creed Executive Leadership Group Companies Corporate Governance CSR Compliance Company AwardsRecognitions FinancialOverviewManagement Policy Message from CEO and COO Financial Highlights CSR Corporate Governance FAQGlossary FAQ About Company Profile Locations Policies Solutions ServicesClinical Trials Commercial Supply Consulting Services DevelopmentManufacturing Laboratory Market Approval Consulting Medical Affairs PatientHealthcare Services Post-marketing Surveillance Regulatory Affairs SalesMarketing SitePatient Support Tailored SolutionsAsia Clinical Trials Japan Market Entry Medical DevicesIVD Oncology Drug Orphan Drug CellGene Therapy Browse All Services NewsEvents Resources Financial Careers Locations Contact Contract Research Organization, Your End-to-End Solutions Provider Contract Research Organization Contract DevelopmentManufacturing Organization Healthcare Contract Sales Organization Japan Market Entry Visit Our Virtual Booth Speak with an Expert Pharmaceutical Development Services CMIC Group pioneered the Contract Research Organization (CRO) business in Japan more than 30 years ago. Since then CMIC has continued as a leading innovator in the industry and has expanded services to encompass the entire pharmaceutical value-chain, including: contract development and manufacturing, healthcare solutions, sales and marketing, Japan market entry solutions and more. We pride ourselves on meeting customers where they are and with exactly what they need to move their products forward. View our services below by selecting the phase of drug development that you are working in: Pre-Clinical Clinical Phase I-III Approval Post-Approval, SalesMarketing Consulting ServicesLaboratoryFormulation DevelopmentClinical TrialsConsulting ServicesContract Development and Manufacturing Organization (CDMO)LaboratoryMedical AffairsRegulatory Affairs ConsultingSite Management Organization (SMO)Consulting ServicesMarketing Authorization Holder (MAH)National Health Insurance / Drug PricingRegulatory Affairs ConsultingConsulting ServicesMedical AffairsPatientHealthcare ServicesPost-Marketing SurveillanceSalesMarketingContract Development and Manufacturing Organization (CDMO)DNP and CMIC HOLDINGS Sign Strategic Alliance Agreement Targeting New Value Creation in Medical and Healthcare Field Read Full Article Japan’s first and largest CRO continues 30-year evolution to help global sponsors navigate the complex local market Access Full Interview Bioanalytical Method Validation: Challenges and Opportunities of a Globally Harmonized System Download Full Report Our Tailored Pharmaceutical Solutions CMIC, Japan's first and largest Contract Research Organization, offers tailored solutions for pharmaceutical companies, medical device manufacturers, academia, bio-ventures and medical institutions. Using our collective strengths, we offer a broad range of services from preclinical research to practical applications. Japanese Market Entry Providing full pharmaceutical capabilities for overseas business partners to enter into Japan market. Learn More Asia Clinical Trials Supporting our client’s clinical trials throughout the Asia Pacific region. Providing solutions for a range of therapeutic areas, registry study, observational study, phases II/III clinical trials, phase IV clinical trials, post-marketing surveillance. Learn More Medical DeviceIVD Consultation services on regulatory issues for the latest medical devices and in vitro diagnostics (IVD). Learn More Oncology Drug Development Specialized oncology staff assists with strategic development planning, including regulatory interaction, conducting clinical studies and post-marketing promotion for companies that wish to enter into the field of oncology. Learn More CellGene Therapy Established systems ready to implement and form development strategies and support every stage of the regenerative medicine lifecycle, including regulatory consulting, various nonclinical and clinical studies, and post-marketing. Learn More Orphan Drug OrphanPacific is a pharmaceutical company within CMIC Group, which provides wealth of experience in the field of orphan drugs: regulatory affairs, supply chain management, quality management and marketing strategy planning. Learn More Speak with an Expert CMIC Contract Research Organization: Latest ResourcesWebinarsC-PRESSVideoWhite PapersScientific PublicationsBrochures Recent News Financial Statement January 31, 2024 Consolidated Financial Results For FY2024 1st Quarter CMIC HOLDINGS Co., Ltd. Consolidated Financial Results For the 1st […] Investor Relations January 31, 2024 Notice of Share Consolidation, Abolition of the Number of Shares Constituting One Unit of Shares, and Partial Amendments to the Articles of Incorporation All News Upcoming Events Events May 31, 2024 ASCO Annual Meeting 2024 Events June 16, 2024 DIA 2024 All Events About CMIC Group Solutions NewsEvents Resources Careers Contact © CMIC HOLDINGS Co., LTD. All rights reserved. X LinkedIn YouTube Information Security Policy Privacy Policy Terms of Use Disclaimer GDPR Compliance For access to this link, please complete this short form. Name * First Last Company Name * Email * Country * Country* Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darrussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Congo, Democratic Republic of the Congo, Republic of the Cook Islands Costa Rica Côte d'Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini (Swaziland) Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard and McDonald Islands Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Northern Mariana Islands Norway Oman Pakistan Palau Palestine, State of Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russia Rwanda Saint Barthélemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau...